[1] Zhong X, Zhang F, Yin X, et al Bone homeostasis and gut microbial-dependent signaling pathways[J]. J Microbiol Biotechnol, 2021, 31(6): 765-774. [2] Grüner N, Ortlepp AL, Mattner J.Pivotal role of intestinal microbiota and intraluminal metabolites for the maintenance of gut-bone physiology[J]. Int J Mol Sci, 2023, 24(6): 5161. [3] Li F, Wang L, Cai Y, et al.Safety assessment of desaminotyrosine: acute, subchronic oral toxicity, and its effects on intestinal microbiota in rats[J]. Toxicol Appl Pharmacol, 2021, 417: 115464. [4] Abusaliya A, Jeong SH, Bhosale PB, et al.Mechanistic action of cell cycle arrest and intrinsic apoptosis via inhibiting Akt/mTOR and activation of p38-MAPK signaling pathways in Hep3B liver cancer cells by prunetrin-a flavonoid with therapeutic potential[J]. Nutrients, 2023, 15(15): 3407. [5] Wei Y, Gao J, Kou Y, et al.The intestinal microbial metabolite desaminotyrosine is an anti-inflammatory molecule that modulates local and systemic immune homeostasis[J]. FASEB J, 2020, 34(12): 16117-16128. [6] Pallu S, Rochefort G Y, Jaffre C, et al.Synchrotron ultraviolet microspectroscopy on rat cortical bone: involvement of tyrosine and tryptophan in the osteocyte and its environment[J]. PLoS One, 2012, 7(8): e43930. [7] Chen R, Wei W, Li L, et al.Non-surgical periodontal therapy and metformin improve bone loss in obese mice with periodontitis by modulating the gut microbiota[J]. FASEB J, 2025, 39(13): e70814. [8] Wali JA, Jarzebska N, Raubenheimer D, et al.Effects of high-fat diets and their underlying mechanisms-a narrative review[J]. Nutrients, 2020, 12(5): 1505. [9] Sakashita H, Yamada S, Kinoshita M, et al.Mice lacking PLAP-1/asporin counteracts high fat diet-induced metabolic disorder and alveolar bone loss by controlling adipose tissue expansion[J]. Sci Rep, 2021, 11(1): 4970. [10] Lu Z, Li Y, Yu H, et al.High-fat diet-induced metabolic syndrome increases ligature-induced alveolar bone loss in mice[J]. Oral Dis, 2023, 29(3): 1312-1323. [11] Li Y, Yu H, Lopes-Virella MF, et al.GPR40/GPR120 agonist GW9508 improves metabolic syndrome-exacerbated periodontitis in mice[J]. Int J Mol Sci, 2024, 25(17): 9622. [12] Li Y, Lu Z, Kirkwood CL, et al.GPR40 deficiency worsens metabolic syndrome-associated periodontitis in mice[J]. J Periodontal Res, 2023, 58(3): 575-587. [13] Silva BR, Hidalgo MAR, Silva RCL, et al.Establishing a dual murine model to explore the interactions between diabetes and periodontitis in mice[J]. Int J Mol Sci, 2025, 26(12): 5611. [14] Sato K, Yamazaki K, Kato T, et al.Obesity-related gut microbiota aggravates alveolar bone destruction in experimental periodontitis through elevation of uric acid[J]. mBio, 2021, 12(3): e0077121. [15] Chen X, He Y, Zhou Y, et al.Modulatory role of exogenous arachidonic acid in periodontitis with type 2 diabetes mellitus mice[J]. BMC Oral Health, 2025, 25(1): 264. [16] Page TH, Smolinska M, Gillespie J, et al.Tyrosine kinases and inflammatory signalling[J]. Curr Mol Med, 2009, 9(1): 69-85. [17] Chen T, Gao F, Luo D, et al.Cistanoside A promotes osteogenesis of primary osteoblasts by alleviating apoptosis and activating autophagy through involvement of the Wnt/β-catenin signal pathway[J]. Ann Transl Med, 2022, 10(2): 64. [18] 张峰, 胡星遥, 李军. 现代饮食习惯对营养均衡的影响及调整策略[J]. 食品安全导刊, 2025, 19(28): 165-167. |